ReviewPharmaceuticals (Basel, Switzerland)2024

Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical Trials.

Silvius Alexandru Pescariu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.